Support Education Research
Please leave this field empty
Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation
eletter banner.jpg
eLetter #711 | May 12, 2017  

Mycophenolate Linked to Improvements with Scleroderma-related Interstitial Lung Disease

Researchers at the University of California David Geffen School of Medicine recently published data indicating that compared to a placebo, treatment with mycophenolate was linked to improvements in physiologic measures and dyspnea in scleroderma patients with interstitial lung disease.

A randomized trial looked at forced vital capacity%-predicted (FVC%) as the primary outcome. Secondary outcomes included diffusing capacity of the lung for carbon monoxide-predicted (DLCO%-predicted) and skin score, as well as dyspnea.


Patients are Driving Factor for Advances in Scleroderma Therapeutics

ideaSome of the leading international pharmaceutical companies have products in clinical trial phases for treatment of scleroderma symptoms. Yet, a recent report from Transparency Market Research (TMR) indicates that key strategic collaborations will be key for advances in the scleroderma diagnostics and therapeutics market.

The scleroderma therapeutics market is driven by several different factors, such as a rise in clinical trials, a high acceptance of new therapies by patients, and new drug approvals for related conditions such as pulmonary arterial hypertension.


National Conference Keynote Speakers Announced

Andrew BotieriWe are pleased to announce this year's keynote speakers for the 19th Annual National Patient Education Conference in Chandler, Ariz.

Returning this year to open the conference is Andrew Botieri, a motivational and thought leader expert. Andrew was diagnosed in 1999 with scleroderma and has authored the book, “A Celebration of Life - A Story of Hope, A Miracle and The Power of Attitude,” about his struggles and challenges of living with scleroderma using perseverance and a positive attitude.

Karen VasquezThis year's closing keynote will be presented by Karen Vasquez, who was diagnosed with scleroderma in 1994. Karen has been working as a scleroderma and chronic disease advocate for more than 20 years and will share how that tenacity saved her life more than once.

Read more and register for the conference

Don't miss news about this year's conference in Arizona. Sign-up for eAlerts today!

Important: Early Bird Registration Ends May 24 

Please note that early registration rates for this year's conference end on Wednesday, May 24. Register soon to take advantage of reduced rates.

Using Writing to Cope with Chronic Illness

WritingWriting helps many people living with chronic illness cope and relieve stress. It can soothe your mind if life is feeling a bit chaotic or overwhelming. Some research studies have shown that it positively helps people work through issues.

You may want to consider setting some time aside each day to reflect about how scleroderma has affected your life through writing. Caring Voice Coalition offers a few writing prompts for people with chronic illness to help get you started.


Quick Links
Contact Us
Become a Member
About Scleroderma
Calendar of Events
Online Chat
Make a gift
2016 Instagram

 actelion new.jpg
Bayer logo
Gilead Logo
reata small
Genentech Logo




Sencis Ad - eLetter

Disclaimer: The Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2019 All rights reserved.